Hypovolemia-induced obesity and diabetes

Metabolism: Clinical and Experimental

Volumn 58, Issue 11, 2009, Pages 1678-

  Fetissov, Serguei O ^a   Thornton, Simon N ^b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN DERIVATIVE; GLUCOSE;

CARBOHYDRATE METABOLISM; CARDIOVASCULAR FUNCTION; FLUID BALANCE; GLUCOSE TRANSPORT; HUMAN; HYPERTENSION; HYPOVOLEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; LIPID METABOLISM; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ADIPOCYTE; BLOOD; METABOLISM; NOTE; PHYSIOLOGY;

ADIPOCYTES; ANGIOTENSINS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; HYPOVOLEMIA; OBESITY; RENIN-ANGIOTENSIN SYSTEM;

EID: 70449713814     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.06.022     Document Type: Letter

References (6)

1. Saiki A., Ohira M., Endo K., et al. Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism 58 (2009) 708-713
2. Thornton S.N. Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer. J Intern Med 265 (2009) 616-617
3. Thornton S.N., Even P.C., and van Dijk G. Hydration increases cell metabolism. Int J Obes (Lond) 33 (2009) 385
4. Thornton S.N. Angiotensin-induced metabolic dysfunction. J Hypertens 27 (2009) 658-659
5. Fetissov S., and Nicolaidis S. Neuropeptide Y in the magnocellular hypothalamic neurons of obese Zucker rats. Neuropeptides 32 (1998) 63-66
6. Schliess F., and Häussinger D. Cell volume and insulin signaling. Int Rev Cytol 225 (2003) 187-228